Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Arq, Inc.ADES · Entity 2240 | Director | July 01, 2020 | July 06, 2020 |
| ModivCare IncPRSC · Entity 76927 | Interim CEO | November 11, 2019 | November 13, 2019 |
| Option Care Health, Inc.OPCH · Entity 4126 | Director | May 20, 2026 | May 22, 2026 |
| Purple Innovation, Inc.PRPL · Entity 7764 | Director | June 20, 2023 | June 22, 2023 |
| Teligent, Inc.TLGT · Entity 134764 | Director | July 21, 2021 | July 22, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Arq, Inc.
Report date July 01, 2020 · Filed July 06, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 34,683 |
Reported balance
After 2020-07-01 transaction · row 1
1 source rowRow 1 · 2020-07-01 · Grant · Acquired 15,242 · Balance 34,683 |
ModivCare Inc
Report date November 11, 2019 · Filed November 13, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 23,317 |
Reported balance
After 2019-11-11 transaction · row 1
1 source rowRow 1 · 2019-11-11 · Sale · Disposed 1,000 · Balance 23,317 |
Option Care Health, Inc.
Report date May 20, 2026 · Filed May 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 20,620 |
Reported balance
After 2026-05-20 transaction · row 1
1 source rowRow 1 · 2026-05-20 · Grant · Acquired 8,997 · Balance 20,620 F1: The reporting person received an award of restricted stock units on May 20, 2026, which vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect $200,000 of value based on the closing price of the issuer's common stock on May 20, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person received an award of restricted stock units on May 20, 2026, which vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect $200,000 of value based on the closing price of the issuer's common stock on May 20, 2026.
Purple Innovation, Inc.
Report date June 20, 2023 · Filed June 22, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 48,714 |
Reported balance
After 2023-06-20 transaction · row 1
1 source rowRow 1 · 2023-06-20 · Grant · Acquired 31,765 · Balance 48,714 |
Teligent, Inc.
Report date July 21, 2021 · Filed July 22, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 150,000 |
Reported balance
After 2021-07-21 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-07-21 · Grant · Acquired 150,000 · Balance 150,000 F1: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. F3: Each non-employee director of the Issuer is entitled to receive an annual grant of restricted stock units ("RSUs") with a value of $75,000 on the date of grant, such grants to be effective as of the date of the 2021 annual meeting of stockholders, and annually thereafter. The closing price of the Issuer's common stock on the date of grant was $0.50. F2: The shares underlying the derivative securities shall vest fully on the first anniversary of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock.
F2: The shares underlying the derivative securities shall vest fully on the first anniversary of grant.
F3: Each non-employee director of the Issuer is entitled to receive an annual grant of restricted stock units ("RSUs") with a value of $75,000 on the date of grant, such grants to be effective as of the date of the 2021 annual meeting of stockholders, and annually thereafter. The closing price of the Issuer's common stock on the date of grant was $0.50.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Red Lion Hotels CORP
Report date March 17, 2021 · Filed March 19, 2021
Section 16 reporting ended · disclosed 2021-03-19. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-03-17 transaction · row 1
1 source rowRow 1 · 2021-03-17 · Disposition to issuer · Disposed 40,643 · Balance 0 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 20, 2026 Filed May 22, 2026 22:07 UTC | Option Care Health, Inc. OPCH · Entity 4126 | GrantCommon Stock | 8,997 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-018300 · rdgdoc.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,620 F1 · shares: The reporting person received an award of restricted stock units on May 20, 2026, which vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect $200,000 of value based on the closing price of the issuer's common stock on May 20, 2026. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:54 UTC | Option Care Health, Inc. OPCH · Entity 4126 | SaleCommon Stock | 30,287 | $32.05 | $970,619.60 |
DisclosureSEC source: 0001437749-26-006650 · rdgdoc.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,623 F1 · price: Reflects the weighted average price of 30,287 shares of common stock of Option Care Health, Inc. sold by the reporting person in multiple transactions on February 27, 2026 with sale prices ranging from $32.00 to $32.275 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 20, 2025 Filed Aug 21, 2025 22:26 UTC | Option Care Health, Inc. OPCH · Entity 4126 | PurchaseCommon Stock | 750 | $27.19 | $20,391.45 |
DisclosureSEC source: 0001437749-25-027538 · rdgdoc.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,910 F1 · price: Reflects the weighted average price of 750 shares of common stock of Option Care Health, Inc. purchased by the reporting person in multiple transactions on August 20, 2025 with purchase prices ranging from $27.18 to $27.1899 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| May 14, 2025 Filed May 19, 2025 22:26 UTC | Option Care Health, Inc. OPCH · Entity 4126 | GrantCommon Stock | 5,034 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-017671 · rdgdoc.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,160 F1 · shares: The reporting person received an award of restricted stock units on May 14, 2025, which vest in equal installments on each of the first, second and third anniversaries of the grant date. The number of restricted stock units granted was calculated to reflect $160,000 of value based on the closing price of the issuer's common stock on May 14, 2025. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 20:21 UTC | Option Care Health, Inc. OPCH · Entity 4126 | SaleCommon Stock | 1,465 | $32.37 | $47,420.73 |
DisclosureSEC source: 0001437749-24-028553 · rdgdoc.xml · nonDerivative · entry 2 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,126 Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 20:21 UTC | Option Care Health, Inc. OPCH · Entity 4126 | GiftCommon Stock | 67,342 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-028553 · rdgdoc.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,591 Read SEC document |
| May 15, 2024 Filed May 17, 2024 20:54 UTC | Option Care Health, Inc. OPCH · Entity 4126 | GrantCommon Stock | 5,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-017510 · rdgdoc.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,933 F1 · shares: The reporting person received an award of restricted stock units on May 15, 2024, which vest in equal installments on each of the first, second and third anniversaries of the grant date. The number of restricted stock units granted was calculated to reflect $160,000 of value based on the closing price of the issuer's common stock on May 15, 2024. Read SEC document |
| May 09, 2024 Filed May 10, 2024 20:26 UTC | Option Care Health, Inc. OPCH · Entity 4126 | GiftCommon Stock | 6,504 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-016027 · rdgdoc.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,608 Read SEC document |
| August 17, 2023 Filed Aug 21, 2023 21:08 UTC | Option Care Health, Inc. OPCH · Entity 4126 | PurchaseCommon Stock | 1,465 | $34.32 | $50,278.80 |
DisclosureSEC source: 0001437749-23-024320 · rdgdoc.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,112 Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 20:00 UTC | Purple Innovation, Inc. PRPL · Entity 7764 | GrantClass A Common Stock | 31,765 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-23-050942 · ownership.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,714 Read SEC document |
| May 17, 2023 Filed Jun 7, 2023 20:24 UTC | Option Care Health, Inc. OPCH · Entity 4126 | GrantCommon Stock | 9,117 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-016873 · rdgdoc.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,647 F1 · shares: The reporting person received an award of restricted stock units on May 17, 2023, which vest in equal installments on each of the first, second and third anniversaries of the grant date. The number of restricted stock units granted was calculated to reflect $257,000 of value based on the closing price of the issuer's common stock on May 17, 2023. Read SEC document |
| May 15, 2023 Filed May 15, 2023 21:10 UTC | Purple Innovation, Inc. PRPL · Entity 7764 | PurchaseClass A Common Stock | 16,949 | $2.95 | $49,999.55 |
DisclosureSEC source: 0001213900-23-039937 · ownership.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,949 Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 22:43 UTC | Option Care Health, Inc. OPCH · Entity 4126 | SaleCommon Stock | 1,928 | $31.97 | $61,638.16 |
DisclosureSEC source: 0001437749-22-023710 · rdgdoc.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,530 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 6, 2021. Read SEC document |
| September 01, 2022 Filed Sep 2, 2022 20:14 UTC | Option Care Health, Inc. OPCH · Entity 4126 | SaleCommon Stock | 1,923 | $30.65 | $58,939.95 |
DisclosureSEC source: 0001437749-22-021817 · rdgdoc.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,458 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 5, 2021. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 20:44 UTC | Option Care Health, Inc. OPCH · Entity 4126 | SaleCommon Stock | 1,923 | $33.37 | $64,170.51 |
DisclosureSEC source: 0001437749-22-018649 · rdgdoc.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,381 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 5, 2021. Read SEC document |
| July 08, 2022 Filed Jul 12, 2022 20:16 UTC | Option Care Health, Inc. OPCH · Entity 4126 | SaleCommon Stock | 1,923 | $30.00 | $57,690.00 |
DisclosureSEC source: 0001437749-22-016998 · rdgdoc.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,304 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 5, 2021. F2 · balance_after: The amount reported following the July 8, 2022 sale includes a correction to the reporting person's holdings from his prior Form 4, which inadvertently overstated his holdings following the reported transactions by 3,843 shares. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 21:28 UTC | Option Care Health, Inc. OPCH · Entity 4126 | SaleCommon Stock, par value $0.0001 | 1,923 | $30.54 | $58,728.42 |
DisclosureSEC source: 0001127602-22-016714 · form4.xml · nonDerivative · entry 2 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,070 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 5, 2021. F2 · balance_after: The amount reported following the June 1, 2022 sale also reflects the December 21, 2022 transaction reported above and the previously-reported intervening award of 8,898 restricted stock units on May 20, 2022. Read SEC document |
| May 20, 2022 Filed May 24, 2022 22:45 UTC | Option Care Health, Inc. OPCH · Entity 4126 | GrantCommon Stock, par value $0.0001 | 8,898 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-015495 · form4.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,275 F1 · shares: The reporting person received an award of restricted stock units on May 20, 2022. The number of restricted stock units granted was calculated to reflect $257,000 of value based on the closing price of the issuer's common stock on May 19, 2022. Read SEC document |
| December 21, 2021 Filed Jun 3, 2022 21:28 UTC | Option Care Health, Inc. OPCH · Entity 4126 | SaleCommon Stock, par value $0.0001 | 5,125 | $27.00 | $138,375.00 |
DisclosureSEC source: 0001127602-22-016714 · form4.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,095 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 5, 2021. Read SEC document |
| July 21, 2021 Filed Jul 22, 2021 16:25 UTC | Teligent, Inc. TLGT · Entity 134764 | GrantRestricted Stock Units · Derivative | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000352998-21-000009 · primary_doc.xml · derivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. F3 · price: Each non-employee director of the Issuer is entitled to receive an annual grant of restricted stock units ("RSUs") with a value of $75,000 on the date of grant, such grants to be effective as of the date of the 2021 annual meeting of stockholders, and annually thereafter. The closing price of the Issuer's common stock on the date of grant was $0.50. F2 · derivative.exercise_date: The shares underlying the derivative securities shall vest fully on the first anniversary of grant. F2 · derivative.expiration_date: The shares underlying the derivative securities shall vest fully on the first anniversary of grant. Read SEC document |
| May 27, 2021 Filed May 27, 2021 14:12 UTC | Teligent, Inc. TLGT · Entity 134764 | PurchaseCommon Stock | 30,000 | $0.55 | $16,491.00 |
DisclosureSEC source: 0000352998-21-000006 · primary_doc.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Read SEC document |
| May 26, 2021 Filed May 28, 2021 20:06 UTC | Option Care Health, Inc. OPCH · Entity 4126 | GrantCommon Stock, par value $0.0001 | 13,626 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-074137 · tm2117815-1_4seq1.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,377 F1 · shares: The reporting person received an award of restricted stock units on May 26, 2021. The number of restricted stock units granted was calculated to reflect $241,000 of value based on the closing price of the issuer's common stock on May 19, 2021, the date of the annual meeting at which directors were elected. Read SEC document |
| May 10, 2021 Filed May 12, 2021 18:10 UTC | Option Care Health, Inc. OPCH · Entity 4126 | PurchaseCommon Stock, par value $0.0001 | 855 | $16.74 | $14,313.81 |
DisclosureSEC source: 0001104659-21-065037 · tm2116030-2_4seq1.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,751 Read SEC document |
| March 17, 2021 Filed Mar 19, 2021 15:23 UTC | Red Lion Hotels CORP RLH · Entity 141073 | Disposition to issuerCommon Stock | 40,643 | $3.50 | $142,250.50 |
DisclosureSEC source: 0001209191-21-022029 · doc4.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 11:24 UTC | Teligent, Inc. TLGT · Entity 134764 | GrantStock Option · Derivative | 2,000 | $0.00 Strike: $1.11 | $0.00 |
DisclosureSEC source: 0001549936-21-000004 · primary_doc.xml · derivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2032-02-22 F2 · price: These securities were granted as part of the Issuer's equity compensation to its non-employee directors. F1 · derivative.exercise_date: These shares shall vest fully 12 months from the date of grant. Read SEC document |
| January 05, 2021 Filed Jan 6, 2021 17:43 UTC | Red Lion Hotels CORP RLH · Entity 141073 | GrantCommon Stock | 5,131 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-002299 · doc4.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,643 F1 · shares: Represents the portion of the first quarter of 2021 director fees paid to the recipient in stock; based on the closing price of RLH common stock on January 4, 2021, of $3.41. F2 · price: Not applicable. Read SEC document |
| October 05, 2020 Filed Oct 7, 2020 17:39 UTC | Red Lion Hotels CORP RLH · Entity 141073 | GrantCommon Stock | 8,027 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-054175 · doc4.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,512 F1 · shares: Represents the portion of fourth quarter 2020 director fees paid to the recipient in stock. Based on the closing price of our common stock on October 1, 2020 of $2.18. F2 · price: Not applicable. Read SEC document |
| July 08, 2020 Filed Jul 10, 2020 14:00 UTC | Red Lion Hotels CORP RLH · Entity 141073 | GrantCommon Stock | 5,514 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-042131 · doc4.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,485 F1 · shares: Represents the portion of third quarter 2020 director fees paid to the recipient in stock. Based on the closing price of our common stock on July 1, 2020 of $2.38. F2 · price: Not applicable. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 22:25 UTC | Arq, Inc. ADES · Entity 2240 | GrantCommon Stock | 15,242 | $0.00 | $0.00 |
DisclosureSEC source: 0001515156-20-000062 · wf-form4_159407433764714.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,683 Read SEC document |
| June 22, 2020 Filed Jun 24, 2020 20:43 UTC | Option Care Health, Inc. OPCH · Entity 4126 | GrantCommon Stock, par value $0.0001 | 15,237 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-076453 · a4.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,896 F1 · shares: The reporting person received an award of restricted stock units on June 22, 2020. The number of restricted stock units granted was calculated to reflect $206,000 of value based on the closing price of the issuer's common stock on May 22, 2020, the date of the annual meeting at which directors were elected. Read SEC document |
| April 08, 2020 Filed Apr 8, 2020 18:28 UTC | Red Lion Hotels CORP RLH · Entity 141073 | GrantCommon Stock | 10,334 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-023966 · doc4.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,971 F1 · shares: Represents the portion of second quarter 2020 director fees paid to the recipient in stock. Based on the closing price of our common stock on April 1, 2020 of $1.27. F2 · price: Not applicable. Read SEC document |
| January 13, 2020 Filed Jan 14, 2020 17:30 UTC | Red Lion Hotels CORP RLH · Entity 141073 | GrantCommon Stock | 4,820 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-003332 · doc4.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,637 F1 · shares: Represents the portion of first quarter 2020 director fees paid to the recipient in stock. Based on the closing price of our common stock on January 2, 2020 of $3.63. F2 · price: Not applicable. Read SEC document |
| January 01, 2020 Filed Jan 3, 2020 23:25 UTC | Arq, Inc. ADES · Entity 2240 | GrantCommon Stock | 974 | $0.00 | $0.00 |
DisclosureSEC source: 0001515156-20-000008 · wf-form4_157809392574540.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,441 Read SEC document |
| December 11, 2019 Filed Dec 11, 2019 21:53 UTC | Option Care Health, Inc. BIOS · Entity 4126 | GrantCommon Stock, par value $0.0001 | 61,493 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-071877 · tm1924596d2_4.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 286,636 Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 11:17 UTC | ModivCare Inc PRSC · Entity 76927 | SaleCommon Stock | 1,000 | $69.67 | $69,665.00 |
DisclosureSEC source: 0001209191-19-056269 · doc4.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Interim CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,317 Read SEC document |
| October 09, 2019 Filed Oct 11, 2019 16:23 UTC | Red Lion Hotels CORP RLH · Entity 141073 | GrantCommon Stock | 2,764 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-053039 · doc4.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,817 F1 · shares: Represents the portion of fourth quarter 2019 director fees paid to the recipient in stock. Based on the closing price of our common stock on October 1, 2019 of $6.33. F2 · price: Not applicable. Read SEC document |
| August 13, 2019 Filed Aug 15, 2019 20:57 UTC | ModivCare Inc PRSC · Entity 76927 | PurchaseCommon Stock | 1,000 | $57.97 | $57,970.00 |
DisclosureSEC source: 0001220754-19-000065 · wf-form4_156591706278417.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Interim CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,317 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in two transactions at prices ranging from $57.86 to $58.00, inclusive. The Reporting Person undertakes to provide to The Providence Service Corporation (the "Company"), any securityholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 06, 2019 Filed Aug 21, 2023 21:08 UTC | Option Care Health, Inc. OPCH · Entity 4126 | Disposition to issuerCash-Settled Restricted Stock Units · Derivative | 27,363 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-024320 · rdgdoc.xml · derivative · entry 2 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,363 shares Expires not disclosed F1 · derivative.exercise_price: Each Cash-Settled Restricted Stock Unit ("Cash-Settled RSU") was the economic equivalent of one share of BioScrip, Inc. ("BioScrip") common stock. Upon vesting, the Cash-Settled RSUs entitled the reporting person to the "Fair Market Value" of one share of BioScrip's common stock on the vesting date, which was $2.67. F2 · derivative.exercise_date: Each Cash-Settled RSU vested upon the completion of the merger of HC Group Holdings I, LLC and HC Group Holdings II, Inc. with and into BioScrip, which was then rebranded as Option Care Health, Inc. F2 · derivative.expiration_date: Each Cash-Settled RSU vested upon the completion of the merger of HC Group Holdings I, LLC and HC Group Holdings II, Inc. with and into BioScrip, which was then rebranded as Option Care Health, Inc. Read SEC document |
| July 11, 2019 Filed Jul 12, 2019 16:55 UTC | Red Lion Hotels CORP RLH · Entity 141073 | GrantCommon Stock | 4,053 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-041950 · doc4.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,053 F1 · shares: Represents the portion of third quarter 2019 director fees paid to the recipient in stock. Based on the closing price of our common stock on July 1, 2019 of $7.19. F2 · price: Not applicable. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 21:21 UTC | Arq, Inc. ADES · Entity 2240 | GrantCommon Stock | 3,509 | $0.00 | $0.00 |
DisclosureSEC source: 0001515156-19-000066 · wf-form4_156218889611253.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,467 Read SEC document |
| June 03, 2019 Filed Jun 5, 2019 21:33 UTC | Option Care Health, Inc. BIOS · Entity 4126 | GrantCash-Settled Restricted Stock Unit · Derivative | 27,363 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020914 · form4.xml · derivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,363 Underlying: Common Stock, $.0001 Par Value · 27,363 shares Expires not disclosed F1 · derivative.exercise_price: Each Cash-Settled Restricted Stock Unit ("Cash-Settled RSU") is the economic equivalent of one share of BioScrip common stock. Upon vesting, each Cash-Settled RSU will entitle the awardee to a cash-payment equal to the "Fair Market Value" (as defined in the Company's 2018 Equity Incentive Plan (the "Plan")) of one share of BioScrip common stock on the vesting date. F2 · derivative.exercise_date: The Cash-Settled RSUs vest and become non-forfeitable on the earlier of (1) the consummation of a Change of Control (as defined in the Plan), and (2) the day before the Company's 2020 Annual Meeting, provided the awardee has remained in continuous service as a member of the Company's Board of Directors through such date. F2 · derivative.expiration_date: The Cash-Settled RSUs vest and become non-forfeitable on the earlier of (1) the consummation of a Change of Control (as defined in the Plan), and (2) the day before the Company's 2020 Annual Meeting, provided the awardee has remained in continuous service as a member of the Company's Board of Directors through such date. Read SEC document |
| February 01, 2019 Filed Feb 7, 2019 16:41 UTC | ModivCare Inc PRSC · Entity 76927 | GrantCommon Stock | 23,317 | $0.00 | $0.00 |
DisclosureSEC source: 0001220754-19-000016 · wf-form4_154957567889279.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Interim CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,317 Read SEC document |
| July 01, 2018 Filed Jul 3, 2018 21:29 UTC | Arq, Inc. ADES · Entity 2240 | GrantCommon Stock | 3,904 | $0.00 | $0.00 |
DisclosureSEC source: 0001515156-18-000080 · wf-form4_153065338022401.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,958 Read SEC document |
| May 03, 2018 Filed May 7, 2018 19:52 UTC | Option Care Health, Inc. BIOS · Entity 4126 | GrantCommon Stock, $.0001 Par Value | 62,738 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-016489 · form4.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,143 F1 · shares: Vests and becomes non-forfeitable on the day before the Company's 2019 Annual Meeting. Read SEC document |
| April 09, 2018 Filed Apr 11, 2018 17:05 UTC | ModivCare Inc PRSC · Entity 76927 | GrantEmployee Stock Option (Right to Buy) · Derivative | 394,000 | $0.00 Strike: $71.67 | $0.00 |
DisclosureSEC source: 0001437749-18-006712 · rdgdoc.xml · derivative · entry 1 Pate R Carter · CIK 0001641406 · Interim CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 394,000 Underlying: Common Stock · 394,000 shares Expires 2021-04-08 F1 · derivative.exercise_date: The options are subject to vesting as follows: (i) 98,500 options will become vested on March 19, 2019 if the Company has achieved its budget for its 2018 fiscal year, subject to certain adjustments, and the Reporting Person remains employed by the Company, and (ii) 98,500 options will become vested on March 19, 2019 subject to Mr. Pate's achievement of other performance metrics if Mr. Pate is then employed, and (iii) 197,000 options will become vested if the Reporting Person remains employed by the Company through June 30, 2019. Read SEC document |
| July 01, 2017 Filed Jul 5, 2017 22:59 UTC | Arq, Inc. ADES · Entity 2240 | GrantCommon Stock | 4,842 | $0.00 | $0.00 |
DisclosureSEC source: 0001515156-17-000092 · wf-form4_149929555175902.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,054 Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 19:04 UTC | Option Care Health, Inc. BIOS · Entity 4126 | GrantCommon Stock, $.0001 Par Value | 28,736 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-022832 · form4.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,405 Read SEC document |
| May 02, 2017 Filed May 4, 2017 16:50 UTC | Option Care Health, Inc. BIOS · Entity 4126 | GrantCommon Stock, $.0001 Par Value | 49,669 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-016819 · form4.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,669 F1 · shares: Vests and becomes non-forfeitable on the day before the Company's 2018 Annual Meeting. Read SEC document |
| November 10, 2016 Filed Nov 14, 2016 14:04 UTC | Option Care Health, Inc. BIOS · Entity 4126 | PurchaseCommon Stock, $.0001 Par Value | 20,000 | $1.30 | $26,000.00 |
DisclosureSEC source: 0001127602-16-066774 · form4.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,000 F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide BioScrip, Inc., any security holder of BioScrip, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.